Addicts' Craving Triggers Differ by Sex

Article

Cravings in cocaine-dependent men appear to be triggered by drug cues while cravings in cocaine-dependent women appear to be triggered by stress, researchers at the Yale School of Medicine report in a study published online Jan. 31 in The American Journal of Psychiatry.

Cravings in cocaine-dependent men appear to be triggered by drug cues while cravings in cocaine-dependent women appear to be triggered by stress, researchers at the Yale School of Medicine report in a study published online Jan. 31 in The American Journal of Psychiatry.

Marc Potenza, MD, PhD, professor of psychiatry, child study, and neurobiology at Yale, and colleagues performed functional magnetic resonance imaging (fMRI) on 30 abstinent cocaine-dependent individuals (16 women and 14 men) and 36 healthy recreational-drinking controls (18 women and 18 men). During the brain scans, subjects were presented with descriptions of situations or events that they found personally stressful as well as cues involving drugs or alcohol.

Among the cocaine-dependent subjects, increased corticostriatal-limbic activity was detected in areas of the brain associated with addiction and motivation, such as the striatum, insula, and anterior and posterior cingulate. However, the increased activity in the brains of cocaine-addicted women occurred during exposure to stressful scripts and in the brains of cocaine-addicted men during the drug and alcohol cues.

Potenza said that the findings suggest that cocaine-dependent women might benefit from stress-reduction therapy while cocaine dependent-men might benefit more from cognitive behavioral therapy or a 12-step program in the vein of Alcoholics Anonymous.

Related Videos
Rebecca A. Andrews, MD: Issues and Steps to Improve MDD Performance Measures
A Voice Detecting Depression? Lindsey Venesky, PhD, Discusses New Data
Daniel Karlin, MD: FDA Grants Breakthrough Designation to MM120 for Anxiety
Leesha Ellis-Cox: Steps to Closing the Bipolar Disorder Diagnosis Gap for Blacks
Daniel Greer, PharmD: Reduction in Rehospitalizations with Antipsychotic Injections for Schizophrenia
Understanding the Link Between Substance Use and Psychiatric Symptoms, with Randi Schuster, PhD
Andrew Miller, PhD: Inventor of KarXT Discusses Pivotal EMERGENT-2 Data
© 2024 MJH Life Sciences

All rights reserved.